If you made any changes in Pure these will be visible here soon.

Research Output 1988 2019

Filter
Article
2019
3 Citations (Scopus)

Effect of OATP1B1 genotypes on plasma concentrations of endogenous OATP1B1 substrates and drugs, and their association in healthy volunteers

Mori, D., Kashihara, Y., Yoshikado, T., Kimura, M., Hirota, T., Matsuki, S., Maeda, K., Irie, S., Ieiri, I., Sugiyama, Y. & Kusuhara, H., Feb 1 2019, In : Drug metabolism and pharmacokinetics. 34, 1, p. 78-86 9 p.

Research output: Contribution to journalArticle

Sulfates
Healthy Volunteers
Genotype
fluvastatin
Pharmaceutical Preparations

Effects of magnesium oxide on pharmacokinetics of L-dopa/carbidopa and assessment of pharmacodynamic changes by a model-based simulation

Kashihara, Y., Terao, Y., Yoda, K., Hirota, T., Kubota, T., Kimura, M., Matsuki, S., Hirakawa, M., Irie, S. & Ieiri, I., Mar 6 2019, In : European Journal of Clinical Pharmacology. 75, 3, p. 351-361 11 p.

Research output: Contribution to journalArticle

Magnesium Oxide
Carbidopa
Levodopa
Pharmacokinetics
Meta-Analysis
3 Citations (Scopus)

Efficacy of DPP-4 inhibitors, GLP-1 analogues, and SGLT2 inhibitors as add-ons to metformin monotherapy in T2DM patients: a model-based meta-analysis

Inoue, H., Tamaki, Y., Kashihara, Y., Muraki, S., Kakara, M., Hirota, T. & Ieiri, I., Feb 1 2019, In : British journal of clinical pharmacology. 85, 2, p. 393-402 10 p.

Research output: Contribution to journalArticle

Glucagon-Like Peptide 1
Metformin
Hypoglycemic Agents
Type 2 Diabetes Mellitus
Meta-Analysis

Elucidation of N1-methyladenosine as a Potential Surrogate Biomarker for Drug Interaction Studies Involving Renal Organic Cation Transporters

Miyake, T., Mizuno, T., Takehara, I., Mochizuki, T., Kimura, M., Matsuki, S., Irie, S., Watanabe, N., Kato, Y., Ieiri, I., Maeda, K., Ando, O. & Kusuhara, H., Nov 1 2019, In : Drug metabolism and disposition: the biological fate of chemicals. 47, 11, p. 1270-1280 11 p.

Research output: Contribution to journalArticle

Drug Interactions
Cations
Biomarkers
Kidney
Pharmaceutical Preparations
3 Citations (Scopus)

Identification of drug transporters contributing to oxaliplatin-induced peripheral neuropathy

Fujita, S., Hirota, T., Sakiyama, R., Baba, M. & Ieiri, I., Feb 2019, In : Journal of Neurochemistry. 148, 3, p. 373-385 13 p.

Research output: Contribution to journalArticle

oxaliplatin
Peripheral Nervous System Diseases
Spinal Ganglia
Platinum
Pharmaceutical Preparations

Microdosing clinical study to clarify pharmacokinetic and pharmacogenetic characteristics of atorvastatin in Japanese hypercholesterolemic patients

Lee, N., Maeda, K., Fukizawa, S., Ieiri, I., Tomaru, A., Akao, H., Takeda, K., Iwadare, M., Niwa, O., Masauji, T., Yamane, N., Kajinami, K., Kusuhara, H. & Sugiyama, Y., Jan 1 2019, (Accepted/In press) In : Drug metabolism and pharmacokinetics.

Research output: Contribution to journalArticle

Pharmacogenetics
Hypercholesterolemia
Pharmacokinetics
Area Under Curve
Therapeutics

Pharmacokinetics, Pharmacodynamics, and Safety of E6011, a Novel Humanized Antifractalkine (CX3CL1) Monoclonal Antibody: A Randomized, Double-Blind, Placebo-Controlled Single-Ascending-Dose Study

Tabuchi, H., Katsurabara, T., Mori, M., Aoyama, M., Obara, T., Yasuda, N., Kawano, T., Imai, T., Ieiri, I. & Kumagai, Y., May 1 2019, In : Journal of Clinical Pharmacology. 59, 5, p. 688-701 14 p.

Research output: Contribution to journalArticle

Pharmacokinetics
Monoclonal Antibodies
Placebos
Safety
Serum

Population Pharmacokinetic Analysis of Phenytoin After Intravenous Administration of Fosphenytoin in Adult and Elderly Epileptic Patients

Higuchi, K., Yamashita, D., Kashihara, Y., Kakara, M., Hirota, T., Hirakawa, M. & Ieiri, I., Oct 1 2019, In : Therapeutic drug monitoring. 41, 5, p. 674-680 7 p.

Research output: Contribution to journalArticle

Phenytoin
Intravenous Administration
Pharmacokinetics
Population
Body Weight

The association of tobacco use with prescription of muscle relaxants, benzodiazepines, and opioid analgesics for non-cancer pain

Takaki, H., Ieiri, I., Shibuta, H., Onozuka, D. & Hagihara, A., Jan 9 2019, In : American Journal on Addictions.

Research output: Contribution to journalArticle

Tobacco Use
Benzodiazepines
Opioid Analgesics
Prescriptions
Pain
2018
1 Citation (Scopus)

Characterization of changes in HbA1c in patients with and without secondary failure after metformin treatments by a population pharmacodynamic analysis using mixture models

Tamaki, Y., Maema, K., Kakara, M., Fukae, M., Kinoshita, R., Kashihara, Y., Muraki, S., Hirota, T. & Ieiri, I., Dec 1 2018, In : Drug metabolism and pharmacokinetics. 33, 6, p. 264-269 6 p.

Research output: Contribution to journalArticle

Metformin
Population
Therapeutics
Electronic Health Records
Glycosylated Hemoglobin A
4 Citations (Scopus)
CpG Islands
Human Activities
Methylation
Skin
Messenger RNA
2 Citations (Scopus)

Nucleosome positioning and gene regulation of the SGLT2 gene in the renal proximal tubular epithelial cells

Takesue, H., Hirota, T., Tachimura, M., Tokashiki, A. & Ieiri, I., Sep 1 2018, In : Molecular Pharmacology. 94, 3, p. 953-962 10 p.

Research output: Contribution to journalArticle

Sodium-Glucose Transport Proteins
Nucleosomes
Epithelial Cells
Kidney
Genes

Population Pharmacodynamic Analysis of Uric Acid–Lowering Effects of Febuxostat Based on Electronic Medical Records in Two Hospitals

Muraki, S., Moriki, K., Shigematsu, S., Fukae, M., Kakara, M., Yamashita, D., Hirota, T., Takane, H., Shimada, M., Hirakawa, M. & Ieiri, I., Mar 1 2018, In : Journal of Clinical Pharmacology. 58, 3, p. 304-313 10 p.

Research output: Contribution to journalArticle

Electronic Health Records
Uric Acid
Population
Blood Urea Nitrogen
Urban Hospitals

Population Pharmacokinetics and Pharmacodynamics of Oral Propranolol in Pediatric Patients With Infantile Hemangioma

Takechi, T., Kumokawa, T., Kato, R., Higuchi, T., Kaneko, T. & Ieiri, I., Oct 1 2018, In : Journal of Clinical Pharmacology. 58, 10, p. 1361-1370 10 p.

Research output: Contribution to journalArticle

Hemangioma
Propranolol
Pharmacokinetics
Pediatrics
Population

Psychological assessment of acute schizophrenia patients who experienced seclusion either alone or in combination with restraint

Eguchi, R., Onozuka, D., Ikeda, K., Kuroda, K., Ieiri, I. & Hagihara, A., May 1 2018, In : International Journal of Psychiatry in Medicine. 53, 3, p. 171-188 18 p.

Research output: Contribution to journalArticle

Schizophrenia
Psychiatry
Psychology
Brief Psychiatric Rating Scale
Hostility
2 Citations (Scopus)
CpG Islands
DNA Methylation
Liver
Proteins
Messenger RNA
2 Citations (Scopus)
Intravenous Administration
Nanoparticles
Pharmacokinetics
Placebos
Research Personnel
1 Citation (Scopus)

The relationship between fine particulate matter (PM) and schizophrenia severity

Eguchi, R., Onozuka, D., Ikeda, K., Kuroda, K., Ieiri, I. & Hagihara, A., Apr 23 2018, In : International Archives of Occupational and Environmental Health.

Research output: Contribution to journalArticle

Particulate Matter
Schizophrenia
Brief Psychiatric Rating Scale
Patient Admission
Air Pollution
2017
7 Citations (Scopus)

Characterization of ADME gene variation in 21 populations by exome sequencing

Hovelson, D. H., Xue, Z., Zawistowski, M., Ehm, M. G., Harris, E. C., Stocker, S. L., Gross, A. S., Jang, I. J., Ieiri, I., Lee, J. E., Cardon, L. R., Chissoe, S. L., Abecasis, G. & Nelson, M. R., Jan 1 2017, In : Pharmacogenetics and Genomics. 27, 3, p. 89-100 12 p.

Research output: Contribution to journalArticle

Exome
Population
Genes
Gene Frequency
8 Citations (Scopus)

Involvement of Organic Cation Transporters in the Kinetics of Trimethylamine N-oxide

Miyake, T., Mizuno, T., Mochizuki, T., Kimura, M., Matsuki, S., Irie, S., Ieiri, I., Maeda, K. & Kusuhara, H., Sep 1 2017, In : Journal of Pharmaceutical Sciences. 106, 9, p. 2542-2550 9 p.

Research output: Contribution to journalArticle

Cations
Kidney
trimethyloxamine
Tetraethylammonium
Tissue Distribution
18 Citations (Scopus)

Small-Dosing Clinical Study: Pharmacokinetic, Pharmacogenomic (SLCO2B1 and ABCG2), and Interaction (Atorvastatin and Grapefruit Juice) Profiles of 5 Probes for OATP2B1 and BCRP

Kashihara, Y., Ieiri, I., Yoshikado, T., Maeda, K., Fukae, M., Kimura, M., Hirota, T., Matsuki, S., Irie, S., Izumi, N., Kusuhara, H. & Sugiyama, Y., Sep 1 2017, In : Journal of Pharmaceutical Sciences. 106, 9, p. 2688-2694 7 p.

Research output: Contribution to journalArticle

Citrus paradisi
Pharmacogenetics
Pharmacokinetics
Sulfasalazine
Pharmaceutical Preparations
2016
9 Citations (Scopus)

Circulating intestine-derived exosomal miR-328 in plasma, a possible biomarker for estimating BCRP function in the human intestines

Gotanda, K., Hirota, T., Saito, J., Fukae, M., Egashira, Y., Izumi, N., Deguchi, M., Kimura, M., Matsuki, S., Irie, S. & Ieiri, I., Aug 30 2016, In : Scientific reports. 6, 32299.

Research output: Contribution to journalArticle

Intestines
Biomarkers
Breast Neoplasms
Proteins
Area Under Curve
19 Citations (Scopus)

Clarification of the mechanism of clopidogrel-mediated drug-drug interaction in a clinical cassette small-dose study and its prediction based on in vitro information

Kim, S. J., Yoshikado, T., Ieiri, I., Maeda, K., Kimura, M., Irie, S., Kusuhara, H. & Sugiyama, Y., Oct 1 2016, In : Drug Metabolism and Disposition. 44, 10, p. 1622-1632 11 p.

Research output: Contribution to journalArticle

clopidogrel
repaglinide
pioglitazone
Drug Interactions
Pharmaceutical Preparations
Human Body
Pharmacokinetics
Pharmaceutical Preparations
Renal Elimination
1 Citation (Scopus)

Population pharmacodynamic analysis of hemoglobin A1c-lowering effects by adding treatment of DPP-4 inhibitors (sitagliptin) in type 2 diabetes mellitus patients based on electronic medical records

Kakara, M., Nomura, H., Ezaki, M., Fukae, M., Hirota, T., Matsubayashi, S., Hirakawa, M. & Ieiri, I., Sep 1 2016, In : Journal of Diabetes and Its Complications. 30, 7, p. 1282-1286 5 p.

Research output: Contribution to journalArticle

Electronic Health Records
pioglitazone
Type 2 Diabetes Mellitus
Hemoglobins
Population
8 Citations (Scopus)

Population pharmacokinetic–pharmacodynamic modeling and model-based prediction of docetaxel-induced neutropenia in Japanese patients with non-small cell lung cancer

Fukae, M., Shiraishi, Y., Hirota, T., Sasaki, Y., Yamahashi, M., Takayama, K., Nakanishi, Y. & Ieiri, I., Nov 1 2016, In : Cancer chemotherapy and pharmacology. 78, 5, p. 1013-1023 11 p.

Research output: Contribution to journalArticle

docetaxel
Neutropenia
Non-Small Cell Lung Carcinoma
Cells
Population
2015
6 Citations (Scopus)

Effects of multiple-dose rifampicin 450 mg on the pharmacokinetics of fexofenadine enantiomers in Japanese volunteers

Akamine, Y., Miura, M., Yasui-Furukori, N., Ieiri, I. & Uno, T., Jan 1 2015, In : Journal of Clinical Pharmacy and Therapeutics. 40, 1, p. 98-103 6 p.

Research output: Contribution to journalArticle

fexofenadine
Rifampin
Volunteers
Pharmacokinetics
P-Glycoprotein

Pharmacogenomics of anti-cancer drugs for individual treatment

Ieiri, I., Feb 1 2015, In : Nippon rinsho. Japanese journal of clinical medicine. 73, p. 120-125 6 p.

Research output: Contribution to journalArticle

Precision Medicine
Drug Monitoring
Pharmacogenetics
Human Genome
Antineoplastic Agents
14 Citations (Scopus)

The change of pharmacokinetics of fexofenadine enantiomers through the single and simultaneous grapefruit juice ingestion

Akamine, Y., Miura, M., Komori, H., Tamai, I., Ieiri, I., Yasui-Furukori, N. & Uno, T., Oct 10 2015, In : Drug metabolism and pharmacokinetics. 30, 5, p. 352-357 6 p.

Research output: Contribution to journalArticle

fexofenadine
Citrus paradisi
Pharmacokinetics
Eating
2014
31 Citations (Scopus)

Addition of bevacizumab enhances antitumor activity of erlotinib against non-small cell lung cancer xenografts depending on VEGF expression

Li, H., Takayama, K., Wang, S., Shiraishi, Y., Gotanda, K., Harada, T., Furuyama, K., Iwama, E., Ieiri, I., Okamoto, I. & Nakanishi, Y., Oct 9 2014, In : Cancer chemotherapy and pharmacology. 74, 6, p. 1297-1305 9 p.

Research output: Contribution to journalArticle

Heterografts
Non-Small Cell Lung Carcinoma
Vascular Endothelial Growth Factor A
Cells
Tumors
13 Citations (Scopus)

Effects of one-time apple juice ingestion on the pharmacokinetics of fexofenadine enantiomers

Akamine, Y., Miura, M., Komori, H., Saito, S., Kusuhara, H., Tamai, I., Ieiri, I., Uno, T. & Yasui-Furukori, N., Jan 1 2014, In : European Journal of Clinical Pharmacology. 70, 9, p. 1087-1095 9 p.

Research output: Contribution to journalArticle

fexofenadine
Malus
Pharmacokinetics
Eating
Anions
8 Citations (Scopus)

Identification and functional characterization of novel nonsynonymous variants in the human multidrug and toxin extrusion 2-K

Nishimura, K., Ide, R., Hirota, T., Kawazu, K., Kodama, S., Takesue, H. & Ieiri, I., Jan 1 2014, In : Drug Metabolism and Disposition. 42, 9, p. 1432-1437 6 p.

Research output: Contribution to journalArticle

Single Nucleotide Polymorphism
Cations
Cell Membrane
Antiporters
Tetraethylammonium
2 Citations (Scopus)

Influences of artificial heart-lung machine operation on the binding sites of albumin: Possibility of an effective administration plan

Totoribe, K., Takamura, N., Ogata, K., Tokunaga, J., Kawai, K., Nakamura, K., Ieiri, I. & Higuchi, S., Jan 1 2014, In : International Journal of Artificial Organs. 37, 2, p. 99-108 10 p.

Research output: Contribution to journalArticle

Heart-Lung Machine
Artificial heart
Artificial Heart
Binding sites
Serum Albumin
10 Citations (Scopus)

Korean, Japanese, and Chinese populations featured similar genes encoding drug-metabolizing enzymes and transporters: A DMET Plus microarray assessment

Yi, S., An, H., Lee, H., Lee, S., Ieiri, I., Lee, Y., Cho, J. Y., Hirota, T., Fukae, M., Yoshida, K., Nagatsuka, S., Kimura, M., Irie, S., Sugiyama, Y., Shin, D. W., Lim, K. S., Chung, J. Y., Yu, K. S. & Jang, I. J., Oct 10 2014, In : Pharmacogenetics and Genomics. 24, 10, p. 477-485 9 p.

Research output: Contribution to journalArticle

Ethnic Groups
Enzymes
Principal Component Analysis
Pharmaceutical Preparations
Population
2 Citations (Scopus)

Mechanism of the 24-hour rhythm of tumor necrosis factor-alpha formed by onset of rheumatoid arthritis

Yoshimatsu, H., Okazaki, F., Ieiri, I. & To, H., Jan 1 2014, In : Chronobiology International. 31, 4, p. 564-571 8 p.

Research output: Contribution to journalArticle

Lymphotoxin-alpha
Rheumatoid Arthritis
Tumor Necrosis Factor-alpha
Cytokines
Serum Amyloid A Protein
4 Citations (Scopus)

Modeling and simulation of bone mineral density response from a phase 2 study of ONO-5334, a new cathepsin K inhibitor, to support dose selection in osteoporosis

Hasegawa, C., Kastrissios, H., Monteleone, J., Ohno, T., Umemura, T., Ohyama, M., Nagase, S., Small, M., Deacon, S., Ogawa, M. & Ieiri, I., Jan 1 2014, In : Journal of Clinical Pharmacology. 54, 8, p. 937-948 12 p.

Research output: Contribution to journalArticle

Cathepsin K
Bone Density
Tablets
Osteoporosis
Pharmacokinetics
6 Citations (Scopus)

Neonatal Dubin-Johnson syndrome: Novel compound heterozygous mutation in the ABCC2 gene

Okada, H., Kusaka, T., Fuke, N., Kunikata, J., Kondo, S., Iwase, T., Nan, W., Hirota, T., Ieiri, I. & Itoh, S., Oct 1 2014, In : Pediatrics International. 56, 5, p. e62-e64

Research output: Contribution to journalArticle

Chronic Idiopathic Jaundice
Bilirubin
Mutation
Missense Mutation
Genes
6 Citations (Scopus)

Population pharmacodynamic analysis of LDL-cholesterol lowering effects by statins and co-medications based on electronic medical records

Kakara, M., Nomura, H., Fukae, M., Gotanda, K., Hirota, T., Matsubayashi, S., Shimomura, H., Hirakawa, M. & Ieiri, I., Oct 1 2014, In : British journal of clinical pharmacology. 78, 4, p. 824-835 12 p.

Research output: Contribution to journalArticle

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Electronic Health Records
LDL Cholesterol
Population
Anticholesteremic Agents
5 Citations (Scopus)

Population pharmacokinetic and pharmacodynamic modeling of different formulations of ono-5334, cathepsin k inhibitor, in caucasian and japanese postmenopausal females

Hasegawa, C., Ohno, T., Umemura, T., Honda, N., Ohyama, M., Nagase, S., Small, M., Deacon, S., Ogawa, M. & Ieiri, I., Jan 1 2014, In : Journal of Clinical Pharmacology. 54, 1, p. 23-34 12 p.

Research output: Contribution to journalArticle

Cathepsins
Tablets
Pharmacokinetics
Bone Resorption
Population
1 Citation (Scopus)
Secretory Phospholipase A2
Hydroxymethylglutaryl-CoA Reductase Inhibitors
LDL Lipoproteins
Endothelial Cells
Tumor Necrosis Factor-alpha
2013
36 Citations (Scopus)

Apple juice greatly reduces systemic exposure to atenolol

Jeon, H., Jang, I. J., Lee, S., Ohashi, K., Kotegawa, T., Ieiri, I., Cho, J. Y., Yoon, S. H., Shin, S. G., Yu, K. S. & Lim, K. S., Jan 2013, In : British Journal of Clinical Pharmacology. 75, 1, p. 172-179 8 p.

Research output: Contribution to journalArticle

Atenolol
Malus
Pharmacokinetics
Water
Healthy Volunteers
17 Citations (Scopus)
5' Flanking Region
DNA methylation
DNA Methylation
placenta
Individuality
2 Citations (Scopus)

Direct and rapid genotyping of SLCO1B1 388A>G and 521T>C in human blood specimens using the SmartAmp-2 method

Yoshida, K., Takano, J., Ishizu, Y., Lezhava, A., Ieiri, I., Maeda, K., Hayashizaki, Y. & Sugiyama, Y., Apr 1 2013, In : AAPS Journal. 15, 2, p. 618-622 5 p.

Research output: Contribution to journalArticle

Genotype
Solute Carrier Organic Anion Transporter Family Member 1b1
Anions
Pharmacokinetics
Pharmaceutical Preparations
24 Citations (Scopus)

Mechanisms of pharmacokinetic enhancement between ritonavir and saquinavir; micro/small dosing tests using midazolam (CYP3A4), fexofenadine (p-Glycoprotein), and pravastatin (OATP1B1) as probe drugs

Ieiri, I., Tsunemitsu, S., Maeda, K., Ando, Y., Izumi, N., Kimura, M., Yamane, N., Okuzono, T., Morishita, M., Kotani, N., Kanda, E., Deguchi, M., Matsuguma, K., Matsuki, S., Hirota, T., Irie, S., Kusuhara, H. & Sugiyama, Y., Jun 1 2013, In : Journal of Clinical Pharmacology. 53, 6, p. 654-661 8 p.

Research output: Contribution to journalArticle

fexofenadine
Saquinavir
Cytochrome P-450 CYP3A
Pravastatin
Ritonavir
36 Citations (Scopus)

MicroRNA-433 negatively regulates the expression of thymidylate synthase (TYMS) responsible for 5-fluorouracil sensitivity in HeLa cells

Gotanda, K., Hirota, T., Matsumoto, N. & Ieiri, I., Aug 2 2013, In : BMC Cancer. 13, 369.

Research output: Contribution to journalArticle

Thymidylate Synthase
MicroRNAs
HeLa Cells
Fluorouracil
Messenger RNA
10 Citations (Scopus)

Role of methotrexate polyglutamation and reduced folate carrier 1 (RFC1) gene polymorphisms in clinical assessment indexes

Ando, Y., Shimada, H., Matsumoto, N., Hirota, T., Oribe, M., Otsuka, E., Ishii, K., Morimoto, T., Ohashi, K. & Ieiri, I., Jan 1 2013, In : Drug metabolism and pharmacokinetics. 28, 5, p. 442-445 4 p.

Research output: Contribution to journalArticle

Reduced Folate Carrier Protein
Methotrexate
Genes
Erythrocytes
2012
12 Citations (Scopus)

Association of multidrug resistance-associated protein 2 single nucleotide polymorphism rs12762549 with the basal plasma levels of phase II metabolites of isoflavonoids in healthy Japanese individuals

Kato, K., Kusuhara, H., Kumagai, Y., Ieiri, I., Mori, H., Ito, S., Nakai, Y., Maeda, K. & Sugiyama, Y., May 1 2012, In : Pharmacogenetics and Genomics. 22, 5, p. 344-354 11 p.

Research output: Contribution to journalArticle

Single Nucleotide Polymorphism
Genistein
Liquid Chromatography
Mass Spectrometry
Metabolomics
6 Citations (Scopus)

Association study of genetic polymorphisms of drug transporters, SLCO1B1, SLCO1B3 and ABCC2, in African-Americans, Hispanics and Caucasians and olmesartan exposure

Endo, S., Fukahori, A., Tokuhiro, S., Shinagawa, A., Walker, J., Yoshihara, K., Ishizuka, H., Ieiri, I. & Sugiyama, Y., Aug 1 2012, In : Journal of Human Genetics. 57, 8, p. 531-544 14 p.

Research output: Contribution to journalArticle

Genetic Polymorphisms
Hispanic Americans
African Americans
Haplotypes
Pharmacokinetics
26 Citations (Scopus)

Comparison of pharmacokinetics, pharmacodynamics, safety, and tolerability of the amyloid β monoclonal antibody solanezumab in japanese and white patients with mild to moderate Alzheimer disease

Uenaka, K., Nakano, M., Willis, B. A., Friedrich, S., Ferguson-Sells, L., Dean, R. A., Ieiri, I. & Siemers, E. R., Jan 1 2012, In : Clinical Neuropharmacology. 35, 1, p. 25-29 5 p.

Research output: Contribution to journalArticle

solanezumab
Amyloid
Alzheimer Disease
Pharmacokinetics
Monoclonal Antibodies